Press Release

Renal Denervation Market to be dominated by Ultrasound ablation type through 2028

Increasing cases of hypertension are expected to drive Global Renal Denervation Market in the forecast period 2024-2028.

According Wto TechSci Research report, “Renal Denervation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, Global Renal Denervation Market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the increasing chronic diseases such as diabetes and obesity, rising prevalence of hypertension, and growing demand for treatment of hypertension along with rising preference of healthcare providers towards minimally invasive procedures for the treatment of resistant hypertension are further expected to increase the demand for Renal Denervation Market in the forecast period. Similarly, an increase in the number of people who smoke and drink alcohol, sedentary and hectic lifestyles, increasing unhealthy dietary patterns, and increasing focus on research and development to develop novel products are expected to become part of the Global Renal Denervation Market during the forecast period due to the adverse effects on such consumptions.

However, the risk of infection that can cause after surgery, the high cost of these techniques, and lack of awareness among people and healthcare providers about new technique is the main factor that will hamper The Global Renal Denervation Market in the forecast period.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Renal Denervation Market"

The global renal denervation market is segmented based on technology, product, therapeutic area, end user and by region.

Based on Technology, The Global Renal Denervation Market can be segmented into Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, and Microinfusion. The Radio frequency segment is expected to dominate the market for the forecast period because increasing demand for safety and time efficiency reduce the injuries to the renal arteries.

Based on Region, the Global Renal Denervation Market can be further divided into North America, Asia Pacific, Europe, Middle East & Africa. North America region is predicted to dominate the market in 2022 and maintain its dominance throughout the forecast period. However, increasing number of research and development activities, changing lifestyle of the population, well advanced technology used in healthcare industry, rising the number of patients demanding for treatment of hypertension, and increasing appropriate treatment will boost the market growth during the forecast period.

Major companies operating in global renal denervation market are:

Medtronic Plc.
Boston Scientific Corporation
Abbott Laboratories, Inc.
Terumo Corporation
Johnson & Johnson
Cordis Corporation
ReCor Medical, Inc. (Otsuka Holdings)
Cardiosonic Ltd
Mercator MedSystems, Inc
Renal Dynamics Limited

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Europe is expected to register the highest growth in the Global Renal Denervation Market on account of the growing popularity for minimally invasive procedures for treatment of resistant hypertension in the region especially in countries like Germany, France, United Kingdom, among others. Similarly, growing adoption of advanced devices and techniques for the treatment of resistant hypertension is further expected to support the market growth. Additionally, increasing cases of drug-resistant hypertension is further expected to propel the market growth till 2028” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Renal Denervation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Microinfusion), By Product (Catheters, Single Electrode Catheter, Multi Electrode Catheter, RF Generator, Others), By Therapeutic Area (Hypertension, Heart Failure, Diabetes, Renal Failure, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition”, has evaluated the future growth potential of global renal denervation market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global renal denervation market.